title: Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure.
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 943 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Maladies Infectieuses, Paris F-75013, France ruxandra.calin@psl.aphp.fr.
authors.forename: Ruxandra
authors.initials: R
authors.lastname: Calin
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France.
authors.forename: Slim
authors.initials: S
authors.lastname: Fourati
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 943 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Maladies Infectieuses, Paris F-75013, France.
authors.forename: Luminita
authors.initials: L
authors.lastname: Schneider
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France.
authors.forename: Agnes
authors.initials: A
authors.lastname: Gautheret-Dejean
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France.
authors.forename: Sidonie
authors.initials: S
authors.lastname: Lambert-Niclot
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France.
authors.forename: Marc
authors.initials: M
authors.lastname: Wirden
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire d'Immunologie, Paris F-75013, France INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Paris F-75013, France.
authors.forename: Guislaine
authors.initials: G
authors.lastname: Carcelain
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 943 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Maladies Infectieuses, Paris F-75013, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Laboratoire de Virologie, Paris F-75013, France.
authors.forename: Anne-Geneviève
authors.initials: AG
authors.lastname: Marcelin
authors.affiliation: Sorbonne Universités, UPMC Paris 06, Paris F-75013, France INSERM-UMR_S 943 Pierre Louis Institute of Epidemiology and Public Health, Paris F-75013, France AP-HP, GH Pitié Salpêtrière, Maladies Infectieuses, Paris F-75013, France.
authors.forename: Roland
authors.initials: R
authors.lastname: Tubiana
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015153:Blotting, Western; D018791:CD4 Lymphocyte Count; D004279:DNA, Viral / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D015483:HIV Antibodies / Q000097:blood*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000276:immunology* / Q000302:isolation & purification; D015235:HLA-B Antigens / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D008297:Male; D008875:Middle Aged; D010949:Plasma / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D019713:Receptors, CCR5 / Q000235:genetics*; D017384:Sequence Deletion; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: C584933:CCR5 protein, human; D004279:DNA, Viral; D015483:HIV Antibodies; D015235:HLA-B Antigens; C484830:HLA-B*57:01 antigen; D012367:RNA, Viral; D019713:Receptors, CCR5
keywords: HIV primo-infection; early treatment; functional cure; reservoir